Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Kobayashi Pharmaceutical Co., Ltd.

Market Cap 397B 2.46B 2.15B 1.99B 1.85B 3.48B 233B 3.51B 23.44B 9.17B 114B 9.23B 9.02B P/E 2026 *
38.1x
P/E 2027 * 28.9x
Enterprise Value 335B 2.07B 1.81B 1.68B 1.56B 2.93B 196B 2.96B 19.76B 7.73B 96.35B 7.78B 7.61B EV / Sales 2026 *
1.93x
EV / Sales 2027 * 1.81x
Free-Float
64.46%
Yield 2026 *
1.99%
Yield 2027 * 2.05%
1 day-2.71%
6 months-1.65%
Current year-1.65%
Current year 34.05
Extreme 34.05
35
1 year 34.05
Extreme 34.05
37.43
3 years 32.48
Extreme 32.485
44.03
5 years 32.48
Extreme 32.485
85.3
10 years 32.48
Extreme 32.485
85.3
Manager TitleAgeSince
President 61 2025-02-28
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer 50 2020-06-30
Director TitleAgeSince
Director/Board Member 55 2004-05-31
Chairman 72 2025-03-27
Director/Board Member 69 2022-02-28
Change 5-day change 1-year change 3-year change Capi.($)
-2.71%-.--% - - 2.44B
-1.80%-1.29%-7.17%-1.18% 350B
+0.66%+0.15%-14.43%-4.07% 125B
-0.91%-0.87%+1.01%+14.24% 71.6B
-0.44%+0.74%-5.26%-18.37% 54.65B
-1.43%-1.54%-16.50%-31.83% 34.79B
-0.33%-5.74%+12.42%-56.60% 30.68B
+0.34%+1.24%+3.07%-6.61% 18.97B
-0.56%+0.94%-33.15%-41.42% 17.95B
-2.13%+0.41%-7.32%+13.84% 17.39B
Average -0.70%+0.53%-7.48%-14.67% 80.11B
Weighted average by Cap. +0.10%+0.69%-7.46%-6.07%

Financials

2026 *2027 *
Net sales 173B 1.07B 938M 867M 809M 1.52B 101B 1.53B 10.22B 4B 49.83B 4.02B 3.94B 180B 1.12B 977M 903M 843M 1.58B 106B 1.6B 10.65B 4.17B 51.94B 4.19B 4.1B
Net income 10.39B 64.29M 56.28M 52.01M 48.54M 90.99M 6.09B 91.91M 613M 240M 2.99B 241M 236M 13.7B 84.74M 74.18M 68.55M 63.99M 120M 8.02B 121M 809M 316M 3.94B 318M 311M
Net Debt -62.21B -385M -337M -311M -291M -545M -36.44B -550M -3.67B -1.44B -17.9B -1.45B -1.41B -69.95B -433M -379M -350M -327M -613M -40.98B -619M -4.13B -1.62B -20.13B -1.63B -1.59B
Logo Kobayashi Pharmaceutical Co., Ltd.
Kobayashi Pharmaceutical Co Ltd is a Japan-based company primarily engaged in the manufacture and sale of healthcare products, daily necessities, and products such as heat packs. The Company operates through two segments including domestic and international. Healthcare products include anmerutsu, eyebon, inochinohaha, naishitoru, and oral hygiene products. Daily necessities include air fresheners/deodorizers, sundries, and food products. The Company also engages in transportation services, the manufacture and sale of synthetic resin containers, real estate management, and advertising planning and production.
Employees
3,731
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
5,340.00JPY
Average target price
5,521.25JPY
Spread / Average Target
+3.39%

Quarterly revenue - Rate of surprise

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!